Markets:

Overview

News

Currencies

International

Treasuries

Elite Pharms Inc (OP:ELTP)

0.2882 +0.0022 (+0.77%)

Streaming Delayed Price Updated: 11:55 AM EDT, Aug 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Elite Pharms Inc

< Previous 1 2 3 Next >

Elite Pharmaceuticals Q1 Earnings Call Highlights ↗

August 14, 2026

Elite Pharmaceuticals (OTCMKTS:ELTP) reported first-quarter fiscal 2027 revenue of $32.4 million and operating profit of $7.5 million, with Chief Financial Officer Carter Ward describing both measures...

Via MarketBeat

Topics Earnings Supply Chain

Elite Pharmaceuticals Reports Q4 2026 Results: Full Earnings Call Transcript ↗

July 02, 2026

Elite Pharmaceuticals (OTC:ELTP) released fourth-quarter financial results and hosted an earnings call on Tuesday. Read the complete transcript below. This content is powered by Benzinga APIs. For...

Via Benzinga

Topics Earnings

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

June 16, 2025

Northvale, New Jersey--(Newsfile Corp. - June 16, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company...

Via Newsfile

Topics Intellectual Property

Elite Pharmaceuticals Announces Commercial Launch of Oxycodone and Acetaminophen Tablets

April 30, 2025

Northvale, New Jersey--(Newsfile Corp. - April 30, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical...

Via Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Information

February 14, 2024

Via ACCESSWIRE

Elite Pharmaceuticals, Inc. Announces First Shipment of Product from New Facility and Packaging Line

March 03, 2025

Northvale, New Jersey--(Newsfile Corp. - March 3, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2025 ended December 31, 2024 and Provides Conference Call Information

February 13, 2025

Northvale, New Jersey--(Newsfile Corp. - February 13, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2025 Financial Results on February 14, 2025

February 10, 2025

Northvale, New Jersey--(Newsfile Corp. - February 10, 2025) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Generic Vyvanse(R)

December 26, 2024

Northvale, New Jersey--(Newsfile Corp. - December 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Hydrocodone Tablets

December 02, 2024

Northvale, New Jersey--(Newsfile Corp. - December 2, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals Receives FDA Approval for Generic Vyvanse

November 18, 2024

Northvale, New Jersey--(Newsfile Corp. - November 18, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2025 Ended September 30, 2024 and Provides Conference Call Information

November 14, 2024

Northvale, New Jersey--(Newsfile Corp. - November 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2025 Financial Results on November 15, 2024

November 07, 2024

Northvale, New Jersey--(Newsfile Corp. - November 7, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals' Generic Adderall(R) Receives Marketing Approval from the Israeli Ministry of Health

October 10, 2024

Northvale, New Jersey--(Newsfile Corp. - October 10, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals Announces Commercial Launch of Acetaminophen and Codeine Phosphate Tablets

October 07, 2024

Northvale, New Jersey--(Newsfile Corp. - October 7, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty pharmaceutical company...

Via Newsfile

Top Analyst Reports For Nvidia, American Express & Wells Fargo ↗

September 27, 2024

Today's Research Daily features new research reports on 16 major stocks, including NVIDIA Corp., American Express Co., and Wells Fargo & Co., as well as two micro-cap stocks Elite Pharmaceuticals, Inc....

Via Talk Markets

Elite Pharmaceuticals Announces Commercial Launch of Generic Methotrexate Sodium

August 27, 2024

Northvale, New Jersey--(Newsfile Corp. - August 27, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q1 2025 ↗

August 14, 2024

Elite Pharmaceuticals just reported results for the first quarter of 2025.

Via InvestorPlace

Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2025 Ended June 30, 2024 and Provides Conference Call Information

August 14, 2024

Northvale, New Jersey--(Newsfile Corp. - August 14, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2025 Financial Results on August 15, 2024

August 09, 2024

Northvale, New Jersey--(Newsfile Corp. - August 9, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

ELTP Stock Earnings: Elite Pharmaceuticals Reported Results for Q4 2024 ↗

July 11, 2024

Elite Pharmaceuticals just reported results for the fourth quarter of 2024.

Via InvestorPlace

Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Conference Call Information

July 01, 2024

Northvale, New Jersey--(Newsfile Corp. - July 1, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

Treasure Hunt: 7 Penny Stocks Wall Street Hasn’t Discovered Yet ↗

June 27, 2024

Dirt cheap and under-the-radar, there's still time to get in early with each of these seven undiscovered penny stocks.

Via InvestorPlace

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2024 Financial Results on July 2, 2024

June 26, 2024

Northvale, New Jersey--(Newsfile Corp. - June 26, 2024) - Elite Pharmaceuticals, Inc. (OTCQB: ELTP) ("Elite" or the "Company"), a specialty...

Via Newsfile

7 Strong Buy Penny Stocks to Buy Now: June 2024 ↗

June 13, 2024

Each of these low-priced seven strong buy penny stocks could do some real heavy lifting for your portfolio.

Via InvestorPlace

Elite Pharmaceuticals Receives FDA Approval for Generic Methotrexate

May 20, 2024

Via ACCESSWIRE

Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024

February 08, 2024

Via ACCESSWIRE

Elite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulant

December 26, 2023

Via ACCESSWIRE

Elite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLC

December 12, 2023

Via ACCESSWIRE

Small Stocks, Big Potential: 7 Penny Stocks Poised for Major Gains in 2024 ↗

December 04, 2023

Wager on these three top penny stocks shining through market uncertainty at this time, poised for a year-end rally.

Via InvestorPlace

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.